[
    {
        "title": "**Protocol I: Procedure for knock-in/knock-out in cultured cells using the VIKING method**",
        "body": []
    },
    {
        "title": "**Day 1: Cell culture**",
        "body": "•  Incubate HaCaT or human embryonic kidney 293F \\(HEK293F) cells in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum and 1 U/mL penicillin-streptomycin \\(D10 medium).\r\n\n\n\\(see Remark 2)."
    },
    {
        "title": "**Day 2: Transfection \\(Fig. 1a)**",
        "body": "- Electroporation method \\(HaCaT cells)\r\n\n\n •  Suspend cells in 400 µL Opti-MEM.\r\n\n\n •  Transfect cells with the VIKING module and the target genome cleavage vector using a total of 15 µg DNA \\(molar ratio of donor cleavage vector \\(VKG1-gRNA-pX330):donor vector \\(pVKG1-PURO):target genome cleavage vector \\(pX330) = 1:1:17) using an electroporator.\r\n\n\n •  Transfer cells to 100 mm dishes and culture in D10 medium lacking antibiotics for 24 h.\r\n\n\n- Lipofection method \\(HEK293F cells).\r\n\n\n •  Suspend cells in 400 µL Opti-MEM.\r\n\n\n •  Transfect cells with the VIKING module and the target genome cleavage vector using a total of 15 µg DNA \\(molar ratio of donor cleavage vector \\(VKG1-gRNA-pX330):donor vector \\(pVKG1-PURO):target genome cleavage vector \\(pX330) = 1:1:17) using TurboFect transfection reagent.\r\n\n\n •  Transfer cells to 100 mm dishes and culture in D10 medium lacking antibiotics for 24 h.\r\n\n\n \\(see Remark 3)."
    },
    {
        "title": "**Day 4: Selection**",
        "body": "•  Refresh D10 medium.\r\n\n\n •  Add puromycin \\(0.3 µg/mL) to the D10 medium and culture cells for 1–2 weeks."
    },
    {
        "title": "**Day 14: Clone picking \\(Fig. 1b)**",
        "body": "•  Wash cells with phosphate-buffered saline.\r\n\n\n •  Place the cloning ring on a single colony. Pick at least 20 colonies. Limiting dilution is also possible．\r\n\n\n •  Add 20 µL trypsin to each ring.\r\n\n\n •  Incubate cells at 37ºC for 2 min \\(HEK293F cells) or 10 min \\(HaCaT cells).\r\n\n\n •  Transfer cells to a 24-well or 48-well plate.\r\n\n\n •  Incubate cells at 37ºC for several days.\r\n\n\n •  Transfer cells to a 12-well plate and incubate.\r\n\n\n •  Isolate a portion of the cells for DNA extraction."
    },
    {
        "title": "**Day 16: DNA extraction**",
        "body": "•  Add 180 µL of 50 mM NaOH and transfer to a 1.5 µL tube.\r\n\n\n •  Incubate at 95ºC for 30 min.\r\n\n\n •  Add 20 µL of 1 M Tris HCl, pH 8.0.\r\n\n\n •  Centrifuge at 12,000 rpm for 10 min.\r\n\n\n •  Transfer the supernatant to a new tube."
    },
    {
        "title": "**Day 17: Genotyping \\(confirmation of knock-in by PCR) \\(Fig. 1c)**",
        "body": [
            "Knock-in and random insertion are confirmed by PCR using the extracted DNA as a template \\(see Remark 4 and",
            {
                "title": "5).",
                "body": "There is no need for a special polymerase.\r\n\n\nGoTaq polymerase is used in this protocol.\r\n\n\n- Design primers to amplify the VKG1 sequence.\r\n\n\nExample:\r\n\n\nPrimer 1 \\(VKG 1_4561 F), 5'-GCCTATGGAAAAACGCCAGC-3'.\r\n\n\nPrimer 2 \\(VKG 1_250 R), 5'-TTCCTGTCTAGCGGTACGCG-3'.\r\n\n\n- Design primers that specifically bind to the target genome sequence.\r\n\n\nExample:\r\n\n\nPrimer 3 \\(VDR genome_del 3 F), 5'-GGTGGGCCTCATGTCTTCTG-3'.\r\n\n\nPrimer 4 \\(VDR genome_del 1 R), 5'-CCTTCATCATGCCGATGTCC-3'."
            }
        ]
    },
    {
        "title": "**Genotyping by PCR**",
        "body": [
            "• PCR sample\r\n\n\n2× GoTaq GreenMaster Mix, 12.5 µL\r\n\n\n10 µM Primer A, 2.5 µL\r\n\n\n10 µM Primer B, 2.5 µL\r\n\n\nNuclease-free water, 6.5 µL\r\n\n\nGenomic DNA, 1 µL\r\n\n\nTotal, 25 µL\r\n\n\n • Thermocycle\r\n\n\n95ºC for 2 min.\r\n\n\n30 cycles of 95°C for 30 sec, 55°C for 1 min, and 72°C for 2 min.\r\n\n\n72ºC for 4 min.\r\n\n\n12ºC hold.\r\n\n\nStep",
            {
                "title": "1.",
                "body": "Confirm random insertion.\r\n\n\nPCR is performed using Primer 1 and Primer 2 for Amplicon1.\r\n\n\nRandom insertion is confirmed by amplification of Amplicon1.\r\n\n\nStep"
            },
            {
                "title": "2.",
                "body": "Confirm knock-in at the target locus.\r\n\n\n- Forward direction\r\n\n\nPCR is performed using Primer 1 and Primer 3 for Amplicon2, or Primer 2 and Primer 4 for Amplicon3.\r\n\n\nKnock-in in the forward direction is confirmed by amplification of Amplicon2 and Amplicon3.\r\n\n\n- Reverse direction\r\n\n\nPCR is performed using Primer 2 and Primer 3 for Amplicon4, or Primer 1 and Primer 4 for Amplicon5.\r\n\n\nKnock-in in the reverse direction is confirmed by amplification of Amplicon4 and Amplicon5."
            }
        ]
    },
    {
        "title": "**Protocol II: Procedure for knock-in in cultured cells using the VIKING method \\(Fig. 2)**",
        "body": []
    },
    {
        "title": "**Day 1–16**",
        "body": "Same as Protocol I."
    },
    {
        "title": "**Day 17: Genotyping**",
        "body": "- Design primers to amplify the VKG1 sequence.\r\n\n\nSame as Protocol I.\r\n\n\n- Design primers to amplify the VKG1 sequence.\r\n\n\nExample:\r\n\n\nPrimer 1 \\(pEN_ObLi_40_For), 5'-TACCGCCTTTGAGTGAGCTG-3'.\r\n\n\nPrimer 2 \\(pEN_ObLi_190_Rev), 5'-AAACCTGTCGTGCCAGCTGC-3'.\r\n\n\n- Design primers that specifically bind to the target genome sequence.\r\n\n\nExample:\r\n\n\nPrimer 3 \\(AAVS_F5), 5'-GGAAATGGGGGTGTGTCACC-3'.\r\n\n\nPrimer 4 \\(AAVS_R6), 5'-CCCTACCCCCCTTACCTCTC-3'."
    },
    {
        "title": "**Genotyping by PCR**",
        "body": "Same as Protocol I."
    },
    {
        "title": "**Remarks**",
        "body": [
            {
                "title": "1.",
                "body": "This vector is selected according to the target locus for knock-in."
            },
            {
                "title": "2.",
                "body": "In addition to HaCaT and HEK293F cells, the VIKING method has been validated in the C4-2 \\(human prostate cancer), UMR-106 \\(rat osteogenic), and MC3T3-E1 \\(mouse preosteoblastic) cell lines."
            },
            {
                "title": "3.",
                "body": "These two transfection methods are examples and should be changed depending on cell lines to attain a high transfection efficiency."
            },
            {
                "title": "4.",
                "body": "The backbone of the donor vector is integrated into the genome in principle."
            },
            {
                "title": "5.",
                "body": "Tandem insertions of the donor vectors sometimes occur."
            }
        ]
    }
]